Canada Pension Plan Investment Board’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-86,600
Closed -$2.25M – 1376
2025
Q2
$2.25M Buy
+86,600
New +$2.09M ﹤0.01% 852
2025
Q1
– Sell
-83,000
Closed -$2.38M – 1335
2024
Q4
$2.38M Hold
83,000
– – ﹤0.01% 848
2024
Q3
$3.13M Buy
+83,000
New +$2.91M ﹤0.01% 791

Other funds holding CGON

Canada Pension Plan Investment Board's CGON Position: Q3 2025 in Review

Canada Pension Plan Investment Board sold out of CG Oncology (CGON) in Q3 2025, closing a stake of 86,600 shares — an estimated $2.25M sold.

Canada Pension Plan Investment Board first reported a position in CGON in Q3 2024 and held it in 3 quarters. The position peaked at $3.13M in Q3 2024. 176 funds tracked by Wall St. Rank hold CGON as of Q3 2025.

  • Canada Pension Plan Investment Board reported no remaining CG Oncology position as of Q3 2025 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 86,600 CG Oncology shares in Q3 2025, an estimated $2.25M.
  • Canada Pension Plan Investment Board first reported a position in CG Oncology in Q3 2024 and held it in 3 quarters.
  • Canada Pension Plan Investment Board's CG Oncology position peaked at $3.13M in Q3 2024.
  • 176 funds tracked by Wall St. Rank held CG Oncology as of Q3 2025.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2025, filed 13 Nov 2025.